Trial Profile
Clot lysis: Evaluating accelerated resolution of intraventricular hemorrhage (IVH)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2022
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Cerebral haemorrhage; Embolism and thrombosis
- Focus Adverse reactions
- Acronyms CLEAR-IVH
- 20 Sep 2012 New source identified and integrated (ISRCTN: Current Controlled Trials, 47341677).
- 16 Jul 2012 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 16 Jul 2012 Additional lead trial investigator (Daniel F Hanley) identified as reported by ClinicalTrials.gov.